Skip to main content

Table 1 Direct medical costs (RMB, thousand Yuan) of hospitalization in different H7N9 patients

From: Economic burden and its associated factors of hospitalized patients infected with A (H7N9) virus: a retrospective study in Eastern China, 2013–2014

  All patients (n = 52) Mild (n = 4) Severe (n = 27) Dead (n = 21) P * P **
  Median (IQR) Proportion, %, median (IQR) Median (IQR) Proportion, %, median (IQR) Median (IQR) Proportion, %, median (IQR) Median (IQR) Proportion, %, median (IQR)   
Total fee 122 260 (60 710–310 220) 100 12 790 (3 320–19 750) 100 96 780 (56 780–287 140) 100 228 650 (116 410–549 520) 100 <0.0001 --
Examination 8 420 (2 920–17 320) 5.0 (2.5–10.6) 530 (150–1 510) 4.6 (3.5–9.4) 8 660 (3 840–14 700) 7.3 (3.2–11.6) 13 900 (3 400–21 540) 2.8 (1.6–9.9) 0.011 0.092
Lab testing 15 350 (8 520–35 570) 11.9 (9.1–14.9) 1 910 (290–3 390) 16.3 (7.8–19.4) 14 600 (8 470–27 950) 13.2 (10.2–15.3) 25 530 (11 120–65 980) 9.7 (7.6–11.5) 0.002 0.009
Medication 63 250 (27 420–212 700) 53.5 (40.1–60.1) 8 080 (1 820–10 170) 55.1 (34.8–65.3) 61 130 (21 280–151 040) 55.2 (47.0–59.8) 137 410 (54 290–345 040) 49.3 (38.0–60.6) 0.001 0.868
 Western medication 58 390 (22 050–190 890) 99.7 (90.6–100.0) 3 520 (780–8 890) 83.6 (36.0–95.9) 55 750 (20 950–146 220) 99.7 (94.6–100.0) 137 220 (54 290–345 030) 99.7 (91.1–100.0) 0.001 0.420
 TCMa 340 (10–2 490) 0.3(0 .0–3.4) 300 (20–1 700) 12.5 (2.2–19.5) 330 (10–2 420) 0.3 (0.0–3.3) 350 (10–4 870) 0.3 (0.0–2.5) 0.812 0.358
 Antibiotics 12 880 (5 370–38 210) 20.8 (11.1–36.3) 2 740 (530–4 950) 57.6 (22.4–68.3) 13 260 (5 870–39 200) 31.4 (16.1–39.0) 19 060 (7 650–43 730) 13.0 (8.1–30.5) 0.014 0.018
 Antiviral 1 930 (840–4 130) 2.5 (0.9–7.8) 390 (20–790) 7.5 (1.7–14.2) 1 820 (980–4 140) 2.9 (1.1–8.0) 2 990 (1 390–4 780) 1.2 (0.6–5.7) 0.016 0.333
Glucocorticoids 2 320 (340–8 560) 2.3 (0.4–13.3) 0 (0–1 930) 0.0 (0.0–19.0) 1 140 (270–6 700) 1.3 (0.3–13.6) 4 660 (1 620–22 830) 4.1 (1.6–13.0) 0.002 0.072
Immunoglobulin 13 880 (0–33 400) 10.4 (0.0–24.4) 0 0.0 5 960 (0–39 100) 10.4 (0.0–31.6) 23 040 (8 290–39 780) 17.0 (9.4–21.5) 0.014 0.025
Treating 13 860 (5 610–65 210) 14.8 (8.3–23.8) 120 (70–2 500) 2.9 (0.8–12.9) 8 770 (4 600–32 350) 11.2 (7.7–18.3) 54 450 (16 170–200 570) 22.9 (14.8–29.8) <0.0001 0.002
Medical Consumables 1 010 (0–16 510) 2.4 (0.0–12.2) 300 (100–2 290) 3.7 (2.2–11.8) 150 (0–6 070) 0.2 (0.0–5.9) 21 630 (0–88 810) 12.6 (0.0–19.1) 0.025 0.020
Sick bed 2 400 (1 340–3 990) 1.4 (0.7–3.2) 320 (1 650–5 260) 4.4 (1.1–14.2) 3 040 (1 430–5 150) 2.1 (1.2–4.3) 2 240 (1 410–3 520) 0.8 (0.5–1.4) 0.021 0.001
Nursing 2 390(790–6 270) 1.5 (0.7–3.3) 340 (160–660) 5.3 (0.9–18.9) 3 170 (1 250–6 620) 2.6 (1.1–4.8) 2 180 (1 490–7 850) 1.3 (0.7–1.5) 0.050 0.033
Other fees 100 (0–810) 0.1 (0.0–1.1) 10 (0–70) 0.1 (0.0–0.3) 310 (70–2 400) 0.4 (0.1–2.0) 60 (0–260) 0.0 (0.0–0.2) 0.022 0.032
  1. *P for fee medians comparisons among patients with different clinical outcomes, using Kruskal-wallis H test
  2. **P for proportion medians comparisons among patients with different clinical outcomes, using Kruskal-wallis H test
  3. aTraditional Chinese Medicines